Clinical Trial Update: Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis

View source ↗

Summary

The update reports clinical outcomes for ulcerative colitis patients managed with escalation and de-escalation of adalimumab in real-world clinical practice.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Ulcerative Colitis | Status: COMPLETED